Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s share price gapped up prior to trading on Tuesday. The stock had previously closed at $9.83, but opened at $10.5350. Aspen Pharmacare shares last traded at $10.5350, with a volume of 136 shares traded.
Aspen Pharmacare Price Performance
The firm has a 50-day moving average of $9.70 and a two-hundred day moving average of $8.74. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.54 and a quick ratio of 1.68.
About Aspen Pharmacare
Aspen Pharmacare is a South African pharmaceutical company headquartered in Durban. Founded in 1997, it develops, manufactures and markets branded and generic medicines for patients and healthcare providers. The company’s product portfolio includes prescription and over-the-counter medicines across a range of therapeutic areas, as well as specialized products such as injectable medicines, anesthetics and treatments for thrombosis. Aspen also operates pharmaceutical manufacturing facilities and supplies medicines to other companies and healthcare markets.
Read More
- Five stocks we like better than Aspen Pharmacare
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
- 3 Pharmaceutical Stocks That Offer Safety and Growth
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
